Name | Number of supported studies | Average coverage | |
---|---|---|---|
regulatory T cell | 9 studies | 24% ± 8% | |
CD4-positive, alpha-beta T cell | 6 studies | 27% ± 10% | |
CD8-positive, alpha-beta T cell | 5 studies | 24% ± 5% | |
effector memory CD8-positive, alpha-beta T cell | 5 studies | 23% ± 7% | |
endothelial cell of lymphatic vessel | 4 studies | 20% ± 4% | |
mucosal invariant T cell | 3 studies | 26% ± 6% | |
naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 24% ± 7% | |
CD4-positive helper T cell | 3 studies | 19% ± 1% | |
T cell | 3 studies | 29% ± 5% | |
natural killer cell | 3 studies | 22% ± 4% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 17% ± 2% | |
lymphocyte | 3 studies | 38% ± 9% |
Insufficient scRNA-seq data for expression of ZNF831 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 371.90 | 577 / 578 | 27% | 0.62 | 317 / 1155 |
thymus | 94% | 222.11 | 616 / 653 | 14% | 0.32 | 85 / 605 |
stomach | 86% | 105.58 | 307 / 359 | 21% | 0.42 | 59 / 286 |
breast | 83% | 103.47 | 382 / 459 | 20% | 0.50 | 229 / 1118 |
lymph node | 0% | 0 | 0 / 0 | 100% | 6.45 | 29 / 29 |
spleen | 100% | 1343.62 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 531.21 | 899 / 929 | 0% | 0 | 0 / 0 |
adipose | 92% | 143.30 | 1113 / 1204 | 0% | 0 | 0 / 0 |
intestine | 76% | 308.94 | 736 / 966 | 8% | 0.22 | 41 / 527 |
skin | 49% | 43.42 | 882 / 1809 | 29% | 0.92 | 139 / 472 |
esophagus | 62% | 55.87 | 895 / 1445 | 16% | 0.31 | 29 / 183 |
brain | 71% | 193.07 | 1872 / 2642 | 7% | 0.11 | 46 / 705 |
prostate | 70% | 83.11 | 172 / 245 | 6% | 0.11 | 28 / 502 |
liver | 65% | 48.65 | 148 / 226 | 5% | 0.10 | 21 / 406 |
uterus | 57% | 45.89 | 97 / 170 | 9% | 0.17 | 41 / 459 |
bladder | 57% | 110.14 | 12 / 21 | 8% | 0.16 | 39 / 504 |
kidney | 39% | 67.22 | 35 / 89 | 24% | 0.47 | 216 / 901 |
tonsil | 0% | 0 | 0 / 0 | 53% | 1.20 | 24 / 45 |
pancreas | 25% | 15.91 | 83 / 328 | 26% | 0.75 | 47 / 178 |
blood vessel | 34% | 39.83 | 458 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 20% | 12.38 | 52 / 258 | 4% | 0.20 | 9 / 230 |
ovary | 21% | 17.79 | 37 / 180 | 1% | 0.03 | 6 / 430 |
heart | 17% | 13.08 | 145 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.05 | 3 / 80 |
muscle | 1% | 1.00 | 11 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZNF831 |
Protein name | Zinc finger protein 831 |
Synonyms | C20orf174 |
Description | |
Accessions | ENST00000371030.4 Q5JPB2 ENST00000637017.1 |